Market Overview:
The global pediatric vaccines market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as rising incidence of infectious diseases among children, increasing government initiatives for immunization, and growing demand for pediatric vaccines in emerging countries. Based on type, the pediatric vaccines market is segmented into diphtheria, influenza, hepatitis, pneumococcal diseases, meningococcal diseases and others. Diphtheria vaccine held the largest share of the global pediatric vaccines market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to rising incidence of diphtheria infections among children across the globe. Influenza vaccine is another major type segmented in this market and it accounted for a significant share of total revenue generated by pediatric vaccines in 2017.
Product Definition:
A pediatric vaccine is a vaccine specifically designed for children. The term usually refers to vaccines against infectious diseases, but it may also refer to other types of vaccines, such as those for cancer or allergies.
Diphtheria:
Diphtheria is an infectious disease caused by the diphtheria toxin. The symptoms include sore throat, fever, and neck stiffness. If not treated at the primary stage, it may lead to heart problems and even death in severe cases. Diphtheria vaccine was one of the first vaccines introduced in immunization programs worldwide after its discovery in 1832.
Influenza:
Influenza is an infectious disease of the upper respiratory system caused by the influenza virus. The flu is generally a contagious disease of humans and can be transmitted from one person to another by droplets or direct contact. Influenza (flu) viruses are found in animals and can also infect humans when they come in contact with contaminated fomites (unwanted objects).
Application Insights:
On the basis of application, the global pediatric vaccines market has been segmented into newborn, infant, child and adolescent. The newborn segment held a major share in 2017 due to increasing incidence of neonatal diseases. Newborns are highly susceptible to infections and require regular vaccination schedules for full immunity against various diseases. As per WHO estimates, around 30-50 million babies are born every year across the world and about 2 million die within one month of birth as a result of pre-term births or low birth weight among other causes. This is expected to drive demand for immunization against vaccine-preventable diseases during this period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as the presence of a large number of vaccine manufacturers, increase in healthcare expenditure, and favorable government initiatives. For instance, according to data published by the Centers for Disease Control & Prevention (CDC) in 2016’s Vaccines Prevent Diseases: A 50-Year Coverage Gap?, pneumococcal vaccines have been included as recommended vaccines for children since 1957. However, only 23% of American infants are currently receiving these immunizations on time or at all.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing target population along with rising incidence rates of pediatric diseases due to lack of immunity or boosters after vaccination programs and low coverage rates. In addition, an increase in international travel has increased awareness about infectious diseases among pediatric populations worldwide which has further boosted regional growth prospects during the forecast period (2018 - 2030).
Growth Factors:
- Increasing incidence of infectious diseases in children
- Growing awareness about the benefits of pediatric vaccines
- Rising demand for preventive healthcare services among parents
- Technological advancements in vaccine development and manufacturing processes
- Expansion of global distribution networks by vaccine manufacturers
Scope Of The Report
Report Attributes
Report Details
Report Title
Pediatric Vaccines Market Research Report
By Type
Diphtheria, Influenza, Hepatitis, Pneumococcal Diseases, Meningococcal Diseases, Others
By Application
Newborn, Infant, Child, Dolescent
By Companies
GlaxoSmithKline, Merck, Pfizer, Sanofi, AstraZeneca, Novartis, Takeda Pharmaceutical, Bavarian Nordic, Baxter, LG Life Sciences, Lupin, S K Chemicals, Mitsubishi Tanabe Pharma, Janssen, Shenzhen Kangtai Biological Products, Sinovac Biotech, Bharat Biotech, Crucell, Dynavax, Serum Institute of India
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
171
Number of Tables & Figures
120
Customization Available
Yes, the report can be customized as per your need.
Global Pediatric Vaccines Market Report Segments:
The global Pediatric Vaccines market is segmented on the basis of:
Types
Diphtheria, Influenza, Hepatitis, Pneumococcal Diseases, Meningococcal Diseases, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Newborn, Infant, Child, Dolescent
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Merck
- Pfizer
- Sanofi
- AstraZeneca
- Novartis
- Takeda Pharmaceutical
- Bavarian Nordic
- Baxter
- LG Life Sciences
- Lupin
- S K Chemicals
- Mitsubishi Tanabe Pharma
- Janssen
- Shenzhen Kangtai Biological Products
- Sinovac Biotech
- Bharat Biotech
- Crucell
- Dynavax
- Serum Institute of India
Highlights of The Pediatric Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diphtheria
- Influenza
- Hepatitis
- Pneumococcal Diseases
- Meningococcal Diseases
- Others
- By Application:
- Newborn
- Infant
- Child
- Dolescent
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pediatric Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pediatric vaccines are vaccines that are specifically designed for use in children. They include vaccines against diseases such as measles, mumps, rubella (German measles), chickenpox, and polio.
Some of the major players in the pediatric vaccines market are GlaxoSmithKline, Merck, Pfizer, Sanofi, AstraZeneca, Novartis, Takeda Pharmaceutical, Bavarian Nordic, Baxter, LG Life Sciences, Lupin, S K Chemicals, Mitsubishi Tanabe Pharma, Janssen, Shenzhen Kangtai Biological Products, Sinovac Biotech, Bharat Biotech, Crucell, Dynavax, Serum Institute of India.
The pediatric vaccines market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pediatric Vaccines Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pediatric Vaccines Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pediatric Vaccines Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pediatric Vaccines Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pediatric Vaccines Market Size & Forecast, 2018-2028
4.5.1 Pediatric Vaccines Market Size and Y-o-Y Growth
4.5.2 Pediatric Vaccines Market Absolute $ Opportunity
Chapter 5 Global Pediatric Vaccines Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pediatric Vaccines Market Size Forecast by Type
5.2.1 Diphtheria
5.2.2 Influenza
5.2.3 Hepatitis
5.2.4 Pneumococcal Diseases
5.2.5 Meningococcal Diseases
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pediatric Vaccines Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pediatric Vaccines Market Size Forecast by Applications
6.2.1 Newborn
6.2.2 Infant
6.2.3 Child
6.2.4 Dolescent
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pediatric Vaccines Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pediatric Vaccines Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pediatric Vaccines Analysis and Forecast
9.1 Introduction
9.2 North America Pediatric Vaccines Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pediatric Vaccines Market Size Forecast by Type
9.6.1 Diphtheria
9.6.2 Influenza
9.6.3 Hepatitis
9.6.4 Pneumococcal Diseases
9.6.5 Meningococcal Diseases
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pediatric Vaccines Market Size Forecast by Applications
9.10.1 Newborn
9.10.2 Infant
9.10.3 Child
9.10.4 Dolescent
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pediatric Vaccines Analysis and Forecast
10.1 Introduction
10.2 Europe Pediatric Vaccines Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pediatric Vaccines Market Size Forecast by Type
10.6.1 Diphtheria
10.6.2 Influenza
10.6.3 Hepatitis
10.6.4 Pneumococcal Diseases
10.6.5 Meningococcal Diseases
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pediatric Vaccines Market Size Forecast by Applications
10.10.1 Newborn
10.10.2 Infant
10.10.3 Child
10.10.4 Dolescent
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pediatric Vaccines Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pediatric Vaccines Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pediatric Vaccines Market Size Forecast by Type
11.6.1 Diphtheria
11.6.2 Influenza
11.6.3 Hepatitis
11.6.4 Pneumococcal Diseases
11.6.5 Meningococcal Diseases
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pediatric Vaccines Market Size Forecast by Applications
11.10.1 Newborn
11.10.2 Infant
11.10.3 Child
11.10.4 Dolescent
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pediatric Vaccines Analysis and Forecast
12.1 Introduction
12.2 Latin America Pediatric Vaccines Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pediatric Vaccines Market Size Forecast by Type
12.6.1 Diphtheria
12.6.2 Influenza
12.6.3 Hepatitis
12.6.4 Pneumococcal Diseases
12.6.5 Meningococcal Diseases
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pediatric Vaccines Market Size Forecast by Applications
12.10.1 Newborn
12.10.2 Infant
12.10.3 Child
12.10.4 Dolescent
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pediatric Vaccines Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pediatric Vaccines Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pediatric Vaccines Market Size Forecast by Type
13.6.1 Diphtheria
13.6.2 Influenza
13.6.3 Hepatitis
13.6.4 Pneumococcal Diseases
13.6.5 Meningococcal Diseases
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pediatric Vaccines Market Size Forecast by Applications
13.10.1 Newborn
13.10.2 Infant
13.10.3 Child
13.10.4 Dolescent
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pediatric Vaccines Market: Competitive Dashboard
14.2 Global Pediatric Vaccines Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Merck
14.3.3 Pfizer
14.3.4 Sanofi
14.3.5 AstraZeneca
14.3.6 Novartis
14.3.7 Takeda Pharmaceutical
14.3.8 Bavarian Nordic
14.3.9 Baxter
14.3.10 LG Life Sciences
14.3.11 Lupin
14.3.12 S K Chemicals
14.3.13 Mitsubishi Tanabe Pharma
14.3.14 Janssen
14.3.15 Shenzhen Kangtai Biological Products
14.3.16 Sinovac Biotech
14.3.17 Bharat Biotech
14.3.18 Crucell
14.3.19 Dynavax
14.3.20 Serum Institute of India
